The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Neuronal LRP1 Knockout in Adult Mice Leads to Impaired Brain Lipid Metabolism and Progressive, Age-Dependent Synapse Loss and Neurodegeneration
Open accessAbstract
The vast majority of Alzheimer's disease (AD) cases are late onset with progressive synapse loss and neurodegeneration. Although the amyloid hypothesis has generated great insights into the disease mechanism, several lines of evidence indicate that other risk factors might precondition the brain to amyloid toxicity. Here, we show that the deletion of a major lipoprotein receptor, low-density lipoprotein receptor-related protein 1 (LRP1), in forebrain neurons in mice leads to a global defect in brain lipid metabolism characterized by decreased brain levels of cholesterol, sulfatide, galactosylceramide, and triglyceride. These lipid deficits correlate with progressive, age-dependent dendritic spine degeneration, synapse loss, neuroinflammation, memory loss, and eventual neurodegeneration. We further show that the levels of glutamate receptor subunits NMDA receptor 1 and Glu receptor 1 are selectively reduced in LRP1 forebrain knock-out mice and in LRP1 knockdown neurons, which is partially rescued by restoring neuronal cholesterol. Together, these studies support a critical role for LRP1 in maintaining brain lipid homeostasis and associated synaptic and neuronal integrity, and provide important insights into the pathophysiological mechanisms in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, the cholesterol depletion hypothesis is in full accordance with the results of in vivo animal studies, in which silencing of lipoprotein receptors, implicated in cholesterol uptake and target of PCSK9, led to cognitive impairment [55,56,57,58,59], which was likely related to neuronal loss.”
From PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer’s disease (2022) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“at the age of 9 months, when LRP1 is sufficiently deleted ( 17”
From APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1 (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LRP1 belongs to the same family as LRP5 and is known to regulate crucial processes that help maintain synaptic integrity and cholesterol homeostasis in the brain.[44][45][46]”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Defects in this protein result in degeneration of dendritic spines and synapses and in neuroinflammation [100].”
From Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome (2019) · cites this paper as [100]
The cited source says what the claim attributes to it.
In the citing paper
“In line with this notion, lower (rather than higher) sulfatide levels were observed in another mouse model with neuron-specific LRP1 deficiency previously (Liu et al., 2010).”
From The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain (2013) · cites this paper as Liu et al., 2010
In the citing paper
“It has been reported that the deletion of Lrp1 driven by CaMKII-Cre was significant in the cortex and hippocampus after 6 months of age [39].”
From LRP1 is a neuronal receptor for α-synuclein uptake and spread (2022) · cites this paper as [39]
In the citing paper
“Cholesterol is essential for neurons, because a lack of cholesterol leads to synapse degeneration, impaired synaptic vesicle exocytosis and neurotransmission, and overall decreased neuronal activity.[42][43][44]”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis
Christopherson, K. S., Ullian, E. M., Stokes, C. C. A., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2004.12.020 · Cited by 1,688
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“Disruptions of ion currents in the postsynaptic glutamate receptor result in part from the loss of surface NMDA receptors (Snyder et al., 2005) or AMPA receptors (Hsieh et al., 2006).”
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81826-7 · Cited by 1,280
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
Self-citationHan, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126
Self-citation
Cited by
Sorted by citations
Items 101–200 of 268
Wang, G., Manaenko, A., Shao, A., Ou, Y., Yang, P., Enkhjargal, B., Nowrangi, D., Zhang, J. H., & Tang, J. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654494 · Cited by 45
Self-citationPhytosterols: Targeting Neuroinflammation in Neurodegeneration
Dash, R., Mitra, S., Ali, M. C., Oktaviani, D. F., Hannan, M. A., Choi, S. M., & Moon, I. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200628022812 · Cited by 47
The long noncoding RNA Synage regulates synapse stability and neuronal function in the cerebellum
Wang, F., Wang, Q., Liu, B., Mei, L., Ma, S., Wang, S., Wang, R., Zhang, Y., Niu, C., Xiong, Z., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00774-3 · Cited by 47
Anesthetic Sevoflurane Reduces Levels of Hippocalcin and Postsynaptic Density Protein 95
Zhang, J., Dong, Y., Zhou, C., Zhang, Y., & Xie, Z. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8746-1 · Cited by 44
Self-citationLipid-Binding Proteins in Brain Health and Disease
Corraliza-Gómez, M., Sánchez, D., & Ganfornina, M. D. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01152 · Cited by 43
Papotti, B., Adorni, M. P., Marchi, C., Zimetti, F., Ronda, N., Panighel, G., Lupo, M. G., Vilella, A., Giuliani, D., Ferri, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012192 · Cited by 41
Kadurin, I., Rothwell, S. W., Lana, B., Nieto‐Rostro, M., & DOLPHIN, A. C. (2017) · Scientific Reports · doi:10.1038/srep43802 · Cited by 42
Brain cholesterol homeostasis and its association with neurodegenerative diseases
Gao, Y., Ye, S., Tang, Y., Tong, W., & Sun, S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105635 · Cited by 38
Lorincz, B., Jury, E. C., Vrablı́k, M., Ramanathan, M. K., & Uher, T. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103088 · Cited by 40
Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease
Zhang, C., Lu, J., Liu, B., Cui, Q., & Wang, Y. (2016) · Aging · doi:10.18632/aging.100887 · Cited by 41
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40
Cholesterol in the CNS: functions, recycling and remyelination
Wuerch, E. C., & Yong, V. W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03490-8 · Cited by 41
Hennen, E., Safina, D., Haußmann, U., Wörsdörfer, P., Edenhofer, F., Poetsch, A., & Faissner, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419812 · Cited by 38
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Bell, A. S., Wagner, J., Rosoff, D. B., & Lohoff, F. W. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105155 · Cited by 36
SERPINE2/Protease Nexin-1 in vivo multiple functions: Does the puzzle make sense?
Monard, D. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.012 · Cited by 37
Qi, G., Mi, Y., & Yin, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01531 · Cited by 38
Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect
Hong, D.-Y., Lee, D.-H., Lee, J., Lee, E.-C., Park, S.-W., Lee, M. R., & Oh, J. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158384 · Cited by 38
Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
Nanjundaiah, S., Chidambaram, H., Chandrashekar, M., & Chinnathambi, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00883-6 · Cited by 36
Ran, C., Graae, L., Magnusson, P. K. E., Pedersen, N. L., Olson, L., & Belin, A. C. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-38 · Cited by 36
Ulatowski, L. M., Ghelfi, M. D., West, R., Atkinson, J., Finno, C. J., & Manor, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101712 · Cited by 36
Nie, Y., Li, S., Yan, T., Ma, Y., Ni, C., Wang, H., & Zheng, H. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004955 · Cited by 35
Passarella, D., Ciampi, S., Liberto, V. D., Zuccarini, M., Ronci, M., Medoro, A., Foderà, E., Frinchi, M., Mignogna, D., Russo, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168921 · Cited by 38
Association between serum lipid levels over time and risk of Parkinson’s disease
Hurh, K., Park, M., Jang, S.-I., Park, E.-C., & Jang, S.-Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-25180-8 · Cited by 35
Neural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 37
Torrico, B., Shaw, A. D., Mosca, R., Vivó-Luque, N., Hervás, A., Fernàndez-Castillo, N., Aloy, P., Bayés, M., Fullerton, J. M., Cormand, B., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180184 · Cited by 34
Gan, M., Jiang, P., McLean, P. J., Kanekiyo, T., & Bu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113237 · Cited by 32
Self-citationLandowski, L. M., Pavez, M., Brown, L. S., Gasperini, R., Taylor, B. V., West, A. K., & Foa, L. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668996 · Cited by 32
Yoo, S., Santos, C., Reynders, A., Marics, I., Malapert, P., Gaillard, S., Charron, A., Ugolini, S., Rossignol, R., Khallouqi, A. E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109884 · Cited by 31
Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease
Guan, X., Iyaswamy, A., Sreenivasmurthy, S. G., Su, C.-F., Zhu, Z., Liu, J., Kan, Y., Cheung, K., Lu, J., Tan, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073609 · Cited by 32
Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Bhute, S., Sarmah, D., Datta, A., Rane, P., Shard, A., Goswami, A., Borah, A., Kalia, K., Dave, K. R., & Bhattacharya, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00104 · Cited by 32
Auderset, L., Pitman, K. A., Cullen, C. L., Pepper, R. E., Taylor, B. V., Foa, L., & Young, K. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564351 · Cited by 30
Cholesterol Metabolism in Neurodegenerative Diseases
He, K., Zhao, Z., Zhang, J., Li, D., Wang, S., & Liu, Q. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0674 · Cited by 30
Self-citationSynaptic Protein Alterations in Parkinson’s Disease
Pienaar, I. S., Burn, D. J., Morris, C. M., & Dexter, D. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8226-9 · Cited by 28
An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle
Holland, S. D., Ramer, L. M., McMahon, S. B., Denk, F., & Ramer, M. S. (2019) · eNeuro · doi:10.1523/eneuro.0025-19.2019 · Cited by 28
Mai, M., Guo, X., Huang, Y. M., Zhang, W., Xu, Y., Zhang, Y., Bai, X., Wu, J., & Zu, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02945-w · Cited by 28
Gulej, R., Patai, R., Ungvari, A., Kállai, A., Tarantini, S., Yabluchanskiy, A., Huffman, D. M., Conboy, M. J., Conboy, I. M., Mika Kivimaki, B., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01657-y · Cited by 29
Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk
Harriott, A. M., Heckman, M. G., Rayaprolu, S., Soto‐Ortolaza, A. I., Diehl, N. N., Kanekiyo, T., Liu, C., Bu, G., Malik, R., Cole, J. W., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12735 · Cited by 28
Self-citationBukiya, A. N., Blank, P. S., & Rosenhouse‐Dantsker, A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081240 · Cited by 28
Tiwari, S. K., Dang, J. W., Lin, N., Qin, Y., Wang, S., & Rana, T. M. (2020) · EMBO Reports · doi:10.15252/embr.201949183 · Cited by 26
Cantando, I., Centofanti, C., D’Alessandro, G., Limatola, C., & Bezzi, P. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1354259 · Cited by 27
Recent research progress on metabolic syndrome and risk of Parkinson’s disease
Li, L., Liu, S., Zhuang, J.-L., Li, M.-M., Huang, Z., Chen, Y., Chen, X., Chen, C., Lin, S., & Ye, L. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0093 · Cited by 30
Dissecting the Association Between Migraine and Stroke
Harriott, A. M., & Barrett, K. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0530-8 · Cited by 27
Moussa, H. Y. A., Shin, K. C., Ponraj, J., Kim, S. J., Ryu, J., Mansour, S. A., & Park, Y. (2023) · Advanced Science · doi:10.1002/advs.202206823 · Cited by 23
LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking
Tanokashira, D., Motoki, K., Minegishi, S., Hosaka, A., Mamada, N., Tamaoka, A., Okada, T., Lakshmana, M. K., & Araki, W. (2015) · eNeuro · doi:10.1523/eneuro.0006-15.2015 · Cited by 25
Alshahrani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Shokr, M. M., Kadasah, S. F., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177830 · Cited by 27
DiBattista, A. M., Dumanis, S. B., Song, J. M., Bu, G., Weeber, E. J., Rebeck, G. W., & Hoe, H.-S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.015 · Cited by 27
Self-citationSong, J., Park, J., Kim, J. H., Choi, J. Y., Kim, J. Y., Lee, K. M., & Lee, J. E. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.1.41 · Cited by 25
Peleg‐Raibstein, D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.645569 · Cited by 24
Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective
Shang, G., Shao, Q., Lv, K., Xu, W., Ji, J., Fan, S., Kang, X., Cheng, F., Wang, X., & Wang, Q. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01217-3 · Cited by 24
Medoro, A., Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Marco, R. D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170628 · Cited by 25
Ge, J., Koutarapu, S., Jha, D., Dulewicz, M., Zetterberg, H., Blennow, K., & Hanrieder, J. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05302 · Cited by 24
Yang, L., Xin, X., Zhang, J., Zhang, L., Dong, Y., Zhang, Y., Mao, J., & Xie, Z. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000279 · Cited by 24
Self-citationDomenger, D., Dea, D., Théroux, L., Moquin, L., Gratton, A. P., & Poirier, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.031 · Cited by 24
Neuronal Protein Farnesylation Regulates Hippocampal Synaptic Plasticity and Cognitive Function
Qu, W., Suazo, K. F., Liu, W., Cheng, S., Jeong, A., Hottman, D. A., Yuan, L., Distefano, M. D., & Li, L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02169-w · Cited by 22
Asante, I., Louie, S. G., & Yassine, H. N. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14907 · Cited by 23
Na, H., Yang, J. B., Zhang, Z., Gan, Q., Tian, H., Rajab, I. M., Potempa, L. A., Tao, Q., & Qiu, W. Q. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.02.013 · Cited by 27
Yu, T., Taussig, M. D., DiPatrizio, N. V., Astarita, G., Piomelli, D., Bergman, B. C., Dell’Acqua, M. L., Eckel, R. H., & Wang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135113 · Cited by 21
Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
Wang, N.-Q., Sun, P.-X., Shen, Q.-Q., & Deng, M.-Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04672-w · Cited by 19
Romeo, R., Glotzbach, K., Scheller, A., & Faissner, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.567253 · Cited by 17
Molecular Characterization of AMPA-Receptor-Containing Vesicles
Peters, J. J., Leitz, J., Oses-Prieto, J. A., Burlingame, A. L., & Brunger, A. T. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.754631 · Cited by 18
Targeting Progranulin as an Immuno-Neurology Therapeutic Approach
Boylan, M. A., Pincetic, A., Romano, G. J., Tatton, N. A., Kenkare-Mitra, S., & Rosenthal, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115946 · Cited by 19
Stenger, C., Pinçon, A., Hanse, M., Royer, L., Comte, A., Koziel, V., Olivier, J. L., Pillot, T., & Yen, F. T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07922.x · Cited by 23
Recruitment of the SNX17-Retriever recycling pathway regulates synaptic function and plasticity
Rivero-Ríos, P., Tsukahara, T., Uygun, T., Chen, A., Chavis, G. D., Giridharan, S. S. P., Iwase, S., Sutton, M. A., & Weisman, L. S. (2023) · Journal of Cell Biology · doi:10.1083/jcb.202207025 · Cited by 17
Zlatic, S. A., Duong, D. M., Gadalla, K. K. E., Murage, B., Ping, L., Shah, R., Fink, J. J., Khwaja, O., Swanson, L. C., Şahin, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104966 · Cited by 17
Faissner, A. (2023) · Frontiers in Network Physiology · doi:10.3389/fnetp.2023.1190240 · Cited by 17
A bidirectional link between sulfatide and Alzheimer’s disease
Zimmer, V. C., Lauer, A. A., Haupenthal, V. J., Stahlmann, C. P., Mett, J., Grösgen, S., Hundsdörfer, B., Rothhaar, T. L., Endres, K., Eckhardt, M., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.021 · Cited by 17
Bres, E. E., Safina, D., Müller, J., Bedner, P., Yang, H., Helluy, X., Shchyglo, O., Jansen, S., Mark, M. D., Esser, A., et al. (2020) · Glia · doi:10.1002/glia.23869 · Cited by 13
Schäfer, I., Kaisler, J., Scheller, A., Kirchhoff, F., Haghikia, A., & Faissner, A. (2019) · Cells · doi:10.3390/cells8121550 · Cited by 16
Testa, G., Giannelli, S., Staurenghi, E., Cecci, R., Floro, L., Gamba, P., Sottero, B., & Leonarduzzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413637 · Cited by 14
“Since deletion of LRP1 in mice forebrain neurons led to defective cerebral lipid metabolism, neuroinflammation, synapse loss, and dendritic spine degeneration [90], it is conceivable that similar outcomes could also originate from LRP1 break-down by PCSK9.”
Ogundele, O. M., Nanakumo, E. T., Ishola, A. O., Michael, O. O., Enye, L. A., Balogun, W. G., Cobham, A. E., & Abdulbasit, A. (2014) · Drug and Chemical Toxicology · doi:10.3109/01480545.2014.975355 · Cited by 14
Lok, K. Z., Manzanero, S., & Arumugam, T. V. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.023 · Cited by 14
Lin, J. H. X., de Rezende, V. L., da Costa, M. D. A., de Oliveira, J., & Gonçalves, C. L. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173522 · Cited by 19
Velmurugan, G. V., Hubbard, W. B., Prajapati, P., Vekaria, H. J., Patel, S. P., Rabchevsky, A. G., & Sullivan, P. G. (2023) · Cells · doi:10.3390/cells12101445 · Cited by 15
Moazzami, K., Power, M. C., Gottesman, R. F., Mosley, T. H., Lutsey, P. L., Jack, C. R., Hoogeveen, R. C., West, N. A., Knopman, D. S., & Alonso, Á. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117324 · Cited by 14
Onaolapo, A. Y., Ojo, F. O., Adeleye, O. O., Falade, J., & Onaolapo, O. J. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230102141154 · Cited by 14
Borràs, C., Canyelles, M., Santos, D., Rotllán, N., Núñez, E., Vázquez, J., Maspoch, D., Cano‐Sarabia, M., Zhao, Q., Carmona‐Iragui, M., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100865 · Cited by 16
Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease
Gu, L., Ju, Y., Hu, M. S., Miao, Z., Li, Q., & Zhang, X. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-022-01139-6 · Cited by 12
Wu, S., Liu, X., Yang, H., Ma, W., & Qin, Z. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.08.2194 · Cited by 13
Kang, S., Lee, J., Ali, D. N., Choi, S. H., Nesbitt, J. J., Min, H.-K. P., Trushina, E. V., & Choi, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-75202-w · Cited by 16
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
Pelucchi, S., Da Dalt, L., De Cesare, G., Stringhi, R., D’Andrea, L., La Greca, F., Cambria, C., Vandermeulen, L., Zianni, E., Musardo, S., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107652 · Cited by 12
Zang, F., Zhu, Y., Zhang, Q., Tan, C., Wang, Q., Xie, C., & Initiative, A. D. N. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13716 · Cited by 10
Borrell-Pages, M., Luquero, A., Vilahur, G., Padró, T., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad159 · Cited by 10
Copper metabolism and cuproptosis in Alzheimer's disease: mechanisms and therapeutic potential
Meng, D., Luo, G., & Liu, P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118354 · Cited by 11
Liu, J. J., Chiu, Y.-T., Chen, C., Huang, P., Mann, M., & Liu‐Chen, L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108324 · Cited by 10
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer’s Disease: A Literature Review
Grao‐Cruces, E., Claro, C., la Paz, S. M., & Nóbrega, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032944 · Cited by 15
Dysregulation of neuroproteasomes by ApoE isoforms drives endogenous Tau aggregationPreprint
Paradise, V., Sabu, M., Bafia, J., Sharif, N., Nguyen, C., Konrad-Vicario, K., Mukim, R. D., Wang, X., Corjuc, B., Fu, J. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518293 · Cited by 10
Valenza, M. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251336192 · Cited by 9
Shcholok, T., & Eftekharpour, E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346541 · Cited by 9
T Cell Co-Stimulation: Inhibition of Immunosuppression?
Sundqvist, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00974 · Cited by 9
Hu, W., Liu, J., Hu, Y., Xu, Q., Deng, T., Wei, M., Lu, L., Mi, J., Bergquist, J., Xu, F., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1044022 · Cited by 9
Huang, P., Jin, L., Lu, J., Gao, Y., & Guo, S.-B. (2021) · Theoretical Chemistry Accounts · doi:10.1007/s00214-021-02754-9 · Cited by 9
Progranulin function and regulation in the CNS
Life, B. E., & Leavitt, B. R. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.004 · Cited by 8
Huang, Y. M., Zhang, W., Guo, X., Zhang, Y., Wu, J., & Zu, H. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100367 · Cited by 9
Statin Usage Increases White Matter Hyperintensities
Goldstein, E. D., Garg, G., Navarro, K., Wolcott, Z. C., Yaghi, S. R., Wong, K., McLean, K., & de Havenon, A. (2022) · The Neurologist · doi:10.1097/nrl.0000000000000448 · Cited by 8
Vučinić, N., Stokić, E., Djan, I., Obreht, D., Veličković, N., Stankov, K., & Djan, M. (2017) · Balkan Journal of Medical Genetics · doi:10.1515/bjmg-2017-0004 · Cited by 9
Park, D. I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.017 · Cited by 9
Han, S., Byun, M. S., Yi, D., Jung, J., Kong, N., Chang, Y. Y., Keum, M., Jung, G. J., Lee, J.-Y., Lee, Y. S., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.131 · Cited by 8
Manna, P. R., Yang, S., Manna, C., Waters, H., Islam, M. A., Reddy, A. P., Rawat, P., & Reddy, P. H. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105969 · Cited by 7
Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System
Passarella, D., Ronci, M., Liberto, V. D., Zuccarini, M., Mudò, G., Porcile, C., Frinchi, M., Iorio, P. D., Ulrich, H., & Russo, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158683 · Cited by 7
Yang, H., Zhou, T., Wang, H., Liu, T., Ueda, K., Zhan, R., Zhao, L., Tong, Y., Tian, X., Zhang, T., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.068 · Cited by 7
Self-citation
Metadata
- Authors
- Liu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., Han, X., Weeber, E. J., & Bu, G.
- Affiliations
- Washington University in St. Louis (US)
- University of South Florida (US)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-12-15
- Volume
- 30
- Issue
- 50
- Pages
- 17068-17078
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3146802
- OpenAlex
- W2032607393
- Cited by
- 268
- References
- 53
- Citations by year
- 2026: 9 · 2025: 25 · 2024: 17 · 2023: 29 · 2022: 34 · 2021: 14 · 2020: 22 · 2019: 14 · 2018: 7 · 2017: 19 · 2016: 14 · 2015: 17 · 2014: 18 · 2013: 13 · 2012: 9
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- Alzheimer's Association
- American Health Assistance Foundation
- Hope Center for Neurological Disorders
- National Institutes of Health
- National Institute on Aging (P01AG030128, R01AG031675, R01AG027924, R01 AG02792405, R01AG031784, R01AG035355)
- National Institute on Deafness and Other Communication Disorders (R21DC010489)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- LRP1, Alzheimer's disease, brain lipid metabolism, synaptic loss, neurodegeneration, neuroinflammation, memory loss, NMDA receptor 1, GluR1, lipoprotein receptors, forebrain neurons, age-related neurodegeneration
- MeSH terms
- Age Factors, Amnesia, Animals, Hippocampus, Nerve Degeneration, Neurons, Synapses, Receptors, N-Methyl-D-Aspartate, Prosencephalon, Receptors, AMPA, Mice, Knockout, Cell Culture Techniques, Low Density Lipoprotein Receptor-Related Protein-1, Dendritic Spines, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
